{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:58:28Z","timestamp":1792979908838,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,2]],"date-time":"2027-06-02T00:00:00Z","timestamp":1811894400000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.contraception.2025.111313","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:15:56Z","timestamp":1764000956000},"page":"111313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Management of bleeding irregularities during contraceptive implant use: A systematic review"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9902-7806","authenticated-orcid":false,"given":"Megan A.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne G.","family":"Folger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Gaffield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura K.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2025.111313_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ph14060548","article-title":"Safety and benefits of contraceptives implants: a systematic review","volume":"14","author":"Rocca","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.contraception.2025.111313_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13625180801959931","article-title":"The effects of Implanon on menstrual bleeding patterns","volume":"13","author":"Mansour","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2025.111313_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(97)00200-X","article-title":"Norplant consensus statement and background review","volume":"57","author":"Fraser","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111313_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0010-7824(01)00181-0","article-title":"Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate","volume":"63","author":"Canto De Cetina","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111313_bib5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0010-7824(96)00085-6","article-title":"Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception","volume":"53","author":"Lei","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111313_bib6","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/humrep\/17.9.2428","article-title":"Fraser IS. Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding","volume":"17","author":"Hickey","year":"2002","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.contraception.2025.111313_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/humrep\/15.suppl_3.30","article-title":"The role of selective oestrogen receptor modulators in the treatment of endometrial bleeding in women using long-acting progestin contraception","volume":"15","author":"Grow","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2025.111313_bib8","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0015-0282(03)00797-0","article-title":"Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding","volume":"80","author":"Chegini","year":"2003","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.contraception.2025.111313_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/humrep\/15.suppl_3.135","article-title":"The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestin-only contraceptives","volume":"15","author":"Vincent","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2025.111313_bib10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0010-7824(91)90077-S","article-title":"Prostaglandin production in human endometrium following continuous exposure to low-dose levonorgestrel released from a vaginal ring","volume":"43","author":"White","year":"1991","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111313_bib11","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.ajpath.2012.02.026","article-title":"Tamoxifen modulates cell migration and expression of angiogenesis-related genes in human endometrial endothelial cells","volume":"180","author":"Helmestam","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.contraception.2025.111313_bib12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0015-0282(01)02997-1","article-title":"Administration of an antiprogesterone up-regulates estrogen receptors in the endometrium of women using Norplant: a pilot study","volume":"77","author":"Glasier","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2025.111313_bib13","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.steroids.2003.08.007","article-title":"Progesterone antagonists and progesterone receptor modulators: an overview","volume":"68","author":"Spitz","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2025.111313_bib14","first-page":"531","article-title":"Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium","volume":"32","author":"Whitaker","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2025.111313_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7303a1","article-title":"U.S. Selected Practice Recommendations for Contraceptive Use, 2024","volume":"73","author":"Curtis","year":"2024","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"10.1016\/j.contraception.2025.111313_bib16","first-page":"Cd003449","article-title":"Treatment of vaginal bleeding irregularities induced by progestin only contraceptives","volume":"2","author":"Abdel-Aleem","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2025.111313_bib17","unstructured":"Snyder E, Clark E, Nguyen AT, Folger S, Whiteman M, Curtis K, et al. Management of bleeding irregularities during contraceptive implant use: a systematic review PROSPERO 2022 CRD42022321596. 2022. \u3008https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42022321596\u3009."},{"key":"10.1016\/j.contraception.2025.111313_bib18","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"10.1016\/j.contraception.2025.111313_bib19","first-page":"Cd003449","article-title":"Treatment of vaginal bleeding irregularities induced by progestin only contraceptives","author":"Abdel-Aleem","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2025.111313_bib20","unstructured":"Covidence systematic review software. 2023. \u3008covidence.org\u3009."},{"key":"10.1016\/j.contraception.2025.111313_bib21","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj"},{"key":"10.1016\/j.contraception.2025.111313_bib22","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"key":"10.1016\/j.contraception.2025.111313_bib23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2025.111313_bib24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.contraception.2025.111313_bib25","unstructured":"GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. 2023. \u3008gradepro.org\u3009."},{"key":"10.1016\/j.contraception.2025.111313_bib26","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.contraception.2005.05.015","article-title":"Tamoxifen treatment of bleeding irregularities associated with Norplant use","volume":"72","author":"Abdel-Aleem","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111313_bib27","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0002-9378(96)70326-5","article-title":"Hormonal treatment for bleeding irregularities in Norplant implant users","volume":"174","author":"Alvarez-Sanchez","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111313_bib28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.contraception.2008.04.003","article-title":"Effects of ethinyl estradiol and ibuprofen compared to placebo on endometrial bleeding, cervical mucus and the postcoital test in levonorgestrel subcutaneous implant users","volume":"78","author":"Archer","year":"2008","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2025.111313_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/humrep\/11.suppl_2.115","article-title":"The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users","volume":"11","author":"Boonkasemsanti","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2025.111313_bib30","first-page":"301","article-title":"Efficacy of celecoxib on controlling irregular uterine bleeding secondary to Jadelle use","volume":"92","author":"Buasang","year":"2009","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.contraception.2025.111313_bib31","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/humrep\/15.9.1969","article-title":"Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel","volume":"15","author":"Cheng","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2025.111313_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2004.05.012","article-title":"Effectiveness and acceptability of vitamin E and low-dose aspirin, alone or in combination, on Norplant-induced prolonged bleeding","volume":"70","author":"d\u2019Arcangues","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111313_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0010-7824(90)90094-C","article-title":"Clinical assessment of treatments for prolonged bleeding in users of Norplant implants","volume":"42","author":"D\u00edaz","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111313_bib34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/AOG.0000000000003896","article-title":"Treatment of unfavorable bleeding patterns in contraceptive implant users: a randomized controlled trial","volume":"136","author":"Edelman","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111313_bib35","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/AOG.0000000000000974","article-title":"Short-term treatment of bothersome bleeding for etonogestrel implant users using a 14-day oral contraceptive pill regimen: a randomized controlled trial","volume":"126","author":"Guiahi","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111313_bib36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/13625187.2016.1210122","article-title":"Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial","volume":"21","author":"Hou","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2025.111313_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0010-7824(99)00059-1","article-title":"The effect of mefenamic acid on controlling irregular uterine bleeding secondary to Norplant use","volume":"60","author":"Kaewrudee","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111313_bib38","first-page":"S64","article-title":"The effect of mefenamic acid on controlling irregular uterine bleeding second to Implanon use","volume":"87 3","author":"Phaliwong","year":"2004","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.contraception.2025.111313_bib39","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.contraception.2005.09.012","article-title":"The effect of tranexamic acid for treatment of irregular uterine bleeding secondary to Norplant use","volume":"73","author":"Phupong","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111313_bib40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.contraception.2016.10.001","article-title":"Tamoxifen for the treatment of breakthrough bleeding with the etonogestrel implant: a randomized controlled trial","volume":"95","author":"Simmons","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111313_bib41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0300-483X(00)00208-0","article-title":"Benefits of vitamin E supplementation to Norplant users--in vitro and in vivo studies","volume":"148","author":"Subakir","year":"2000","journal-title":"Toxicology"},{"key":"10.1016\/j.contraception.2025.111313_bib42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/jog.14195","article-title":"Management of bleeding irregularities among etonogestrel implant users: is combined oral contraceptives pills or nonsteroidal anti-inflammatory drugs the better option?","volume":"46","author":"Upawi","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.contraception.2025.111313_bib43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/humrep\/dei273","article-title":"A pilot study to assess the effect of three short-term treatments on frequent and\/or prolonged bleeding compared to placebo in women using Implanon","volume":"21","author":"Weisberg","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2025.111313_bib44","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/humrep\/dep081","article-title":"A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users","volume":"24","author":"Weisberg","year":"2009","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.contraception.2025.111313_bib45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/humrep\/11.suppl_2.109","article-title":"Oestrogen treatment for increased bleeding in Norplant users: preliminary results","volume":"11","author":"Witjaksono","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2025.111313_bib46","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/AOG.0000000000002810","article-title":"Ulipristal acetate for unscheduled bleeding in etonogestrel implant users: a randomized controlled trial","volume":"132","author":"Zigler","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111313_bib47","unstructured":"Centers for Disease Control and Prevention. Supplementary Appendix. U.S. Selected Practice Recommendations for Contraceptive Use, 2024. 2024. \u3008https:\/\/stacks.cdc.gov\/view\/cdc\/156517\u3009."},{"key":"10.1016\/j.contraception.2025.111313_bib48","series-title":"Implantable contraception. Speroff & Darney's Clinical Guide to Contraception","first-page":"133","author":"Cohen","year":"2020"},{"key":"10.1016\/j.contraception.2025.111313_bib49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.contraception.2022.05.011","article-title":"Recommendations for standardization of bleeding data analyses in contraceptive studies","volume":"112","author":"Creinin","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111313_bib50","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.contraception.2016.12.010","article-title":"Shared decision making in contraceptive counseling","volume":"95","author":"Dehlendorf","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111313_bib51","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.amepre.2018.06.006","article-title":"Client preferences for contraceptive counseling: a systematic review","volume":"55","author":"Fox","year":"2018","journal-title":"Am J Prev Med"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425005049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425005049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T19:51:07Z","timestamp":1780861867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782425005049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":51,"alternative-id":["S0010782425005049"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2025.111313","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of bleeding irregularities during contraceptive implant use: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2025.111313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111313"}}